AZTA vs TECH · rev $159.2M vs P/E 65, rev $1.22B
Azenta Inc (AZTA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Azenta Inc (AZTA) is a medical instruments & supplies company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AZTA revenue for 2025-09-30 was $159.2M. Net income was $50.9M. Revenue was up 10.7% from 2025-06-30 to 2025-09-30. AZTA currently screens at market cap $1.05B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AZTA currently screens at market cap $1.05B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AZTA and TECH stock pages for the full models.
Not investment advice.